Chemical Compound
15-keto-prostaglandin E2
CAS Registry Number
26441-05-4
Primary Record
15-keto-prostaglandin E2
- In stock
- 6,062 g
- Purity
- 99.4 %
- CAS
- 26441-05-4
Compound Identifiers & Properties
- CAS
- 26441-05-4
- PubChem CID
- 5280719
- SMILES
- CCCCCC(=O)/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O
- Canonical SMILES
- CCCCCC(=O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
Names & Synonyms
- 15-keto-prostaglandin E2
- 15-Ketoprostaglandin E2
- 15-Keto-PGE2
- 15-Oxo-PGE2
- 15-keto Prostaglandin E2
- 26441-05-4
- 15-Oxoprostaglandin E2
- AC1NQXHH
- 15-keto-PGE2-alpha
- 15-KetoPGE2
- 15-Oxo-PGE2-alpha
- 15-Dehydroprostaglandin E2
- RefChem:908178
- 2S0F1FTK13
- UNII-2S0F1FTK13
- 15-KETO PGE2
- 15-dehydro-prostaglandin E2
- Dinoprostone EP Impurity F
- 15-OXO-DINOPROSTONE
- DTXSID401317991
- CHEBI:15547
- YRTJDWROBKPZNV-KMXMBPPJSA-N
- BML1-F11
- orb1944523
- CHEMBL1447369
- SCHEMBL11681397
- DTXCID901747783
- HMS3648H19
- C20H30O5
- 15-deoxy-15-oxo-prostaglandin E2
- 1238AH
- EX-A10775
- LMFA03010030
- MFCD00065754
- ZINC13540213
- 9,15-Dioxo-11-hydroxyprosta-5,13-dienoic acid
- AT39645
- C20-H30-O5
- CID5280719
- 9,15-dioxo-11R-hydroxy-5Z,13E-prostadienoic acid
- CID:5280719
- SMP2_000019
- Dinoprostone EP Impurity F (Free Base)
- NCGC00161286-01
- DA-69488
- PD020583
- SID:135653593
- HY-113205
- J346.055J
- 15-ketoprostaglandin E2, (11alpha)-isomer
- CS-0059313
- DINOPROSTONE IMPURITY F [EP IMPURITY]
- FT-0638604
- C04707
- (5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprosta-13-enoate
- Prosta-5,13-dien-1-oic acid, 11-hydroxy-9,15-dioxo-, (5Z,11alpha,13E)-
- (5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate
- (Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid
- C026346
- SR-01000946431
- A1243906
- SR-01000946431-1
- 9,15-Dioxo-11alpha-hydroxy-prosta-5Z,13E-dien-1-oic acid
- Q27098095
- (5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate
- (Z)-7-((1R,2R,3R)-3-Hydroxy-5-oxo-2-((E)-3-oxooct-1-en-1-yl)cyclopentyl)hept-5-enoic acid
- (5Z,13E)-11-alpha-hydroxy-9,15-dioxoprost-5,13-dienoate
- (5Z,13E)-11alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate
- 9,15-Dioxo-11.alpha.-hydroxyprosta-5Z,13E-dien-1-oic acid
- (5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate
- (5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoic acid
- (5Z,11R,13E)-11-Hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid
- (5Z,11R,13E)-11-Hydroxy-9,15-dioxoprosta-5,13-dienoic acid
- (5Z,13E)-11-alpha-hydroxy-9,15-dioxoprost-5,13-dienoic acid
- (5Z,13E)-11alpha-Hydroxy-9,15-dioxo-5,13-prostadiene-1-oic acid
- (5Z,13E)-11alpha-Hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-11alpha-hydroxy-9,15-dioxoprosta-5,13-dienoic acid
- (5Z,13E)-9,15-Dioxo-11alpha-hydroxyprosta-5,13-diene-1-oic acid
- DINOPROSTONE IMPURITY, 15-OXO-DINOPROSTONE- [USP IMPURITY]
- Prosta-5,13-dien-1-oic acid, 11-hydroxy-9,15-dioxo-, (5Z,11.alpha.,13E)-
- (5Z,11R,13E)-11-Hydroxy-9,15-dioxoprosta-5,13-diene-1-oic acid
- (5Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl]hept-5-enoic acid
- (Z)-7-((1R,2R,3R)-3-HYDROXY-2-((E)-3-OXO-OCT-1-ENYL)-5-OXOCYCLOPENTYL)HEPT-5-ENOIC ACID